Our expanded South-East Asia footprint and consistent focus on clinician engagement in FY23, provides Monash IVF Group with a solid international foundation heading into FY24.
In FY23, Monash IVF Group strengthened our regional leadership processes by further integrating embryology and introducing a Medical Advisory Committee consisting of leading experts in Singapore, Malaysia, and Indonesia.
A special event that took place during the year was the Monash IVF Singapore Inaugural Reproductive Medicine Update 2023 with participation from across South- East Asia and beyond. The Symposium attracted clinical and embryology experts from world renowned organisations across Europe, Asia and Australia. The event was widely attended with over 250 delegates, and specialties included Fertility, Embryology, Onco-fertility and IVF nursing. The conference was supported by numerous leading equipment and pharmaceutical manufacturers.
Monash IVF Group further invested in its brand regionally, through increased marketing activities of Monash IVF Singapore, and Monash IVF – KPJ. Furthermore, Bali Fertility Centre was co-branded with Monash IVF.
Our recent investment in clinicians, science, marketing and nursing in SE Asia provides a strong platform to capitalise on the attractive growth opportunities in the region. We continue to focus on optimising our existing clinics and building the pipeline of potential future acquisitions, partnerships and Greenfield sites.